News
-
-
COMMUNIQUÉ DE PRESSE
Heidelberg Pharma Announces First Patient Dosed in Phase I Study of Amanitin-based ADC Candidate HDP-102 for Non-Hodgkin Lymphoma
Heidelberg Pharma dosed first patient in Phase I study of Amanitin-based ADC HDP-102 for Non-Hodgkin Lymphoma. ATAC technology targeting CD37. Promising data presented at AACR 2024 -
COMMUNIQUÉ DE PRESSE
Southern Energy Corp. Announces First Quarter 2025 Financial and Operating Results
Southern Energy Corp. reports Q1 2025 financial and operating results, highlighting increase in natural gas sales and premium over NYMEX HH benchmark. Company undergoes strategic financial actions and plans for near-term production growth -
-
-
-
COMMUNIQUÉ DE PRESSE
Beowolff Capital Announces to Launch Voluntary Public Takeover and Delisting Offer for artnet AG
Beowolff Capital announces voluntary public takeover and delisting offer for artnet AG by Leonardo Art Holdings GmbH. Offer price of €11.25 per share with a 97% premium. Transaction aims to strengthen art market -
COMMUNIQUÉ DE PRESSE
Beowolff Capital Announces to Launch Voluntary Public Takeover and Delisting Offer for artnet AG
Beowolff Capital announces a voluntary public takeover and delisting offer for artnet AG, providing shareholders with immediate value crystallization. The offer includes an all-cash consideration of €11.25 per share -
COMMUNIQUÉ DE PRESSE
PFISTERER reports strong order intake and solid start to 2025 – Adjusted EBITDA margin improves to 20.9%
PFISTERER reports strong order intake and solid start to 2025 with adjusted EBITDA margin at 20.9%. Order intake and profit grow significantly, positioning the company well for continued growth -
